Why MicroStrategy Incorporated (MSTR) Soared on Tuesday
We recently published an article titled These 10 Stocks Defied Tuesday’s Bloodbath. In this article, we are going to take a ...
Why Did Metsera Stock Surge 15% On The Worst Trading Day Of 2025? Here's What Has Happened Since Its Listing
The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.
Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending Recently
We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...
Is Amneal Pharmaceuticals, Inc. (AMRX) the Best Weight Loss Drug Stock to Buy According to Analysts?
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Amneal projects $3B-$3.1B revenue in 2025 with biosimilars and CREXONT as key drivers
Discover key insights from Amneal Pharmaceuticals' Q4 2024 earnings, including revenue growth, CREXONT's market success, and biosimilar expansion.
Finanznachrichten6d
CenExel Research: CenExel Supports Metsera, Inc. in Successful Phase II Trial of MET-097 for Obesity and Metabolic Diseases
SALT LAKE CITY, UTAH / ACCESS Newswire / February 27, 2025 / CenExel is pleased to announce its partnership with Metsera, Inc., a clinical-stage biopharmaceutical company dedicated to advancing ...
BioSpace6d
Kallyope Discreetly Drops Disappointing Data for Oral Obesity Candidate
While Kallyope’s drugs are mechanistically unique, the biotech is competing in a crowded space, with other therapies that ...
Is Amneal Pharmaceuticals, Inc. (AMRX) the Best Low Price Pharma Stock to Invest In Right Now?
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...